International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Newer Anti Epileptic Drugs

Dr. Neera Chaudhry, Dr. Abhilekh Srivastava, Dr. Cankatika Choudhury

Abstract: Epilepsy is a disorder of the brain characterized byOn 1 or 2 antiepileptic drugs, around 70-80 % of people with newly diagnosed epilepsy will eventually achieve remission an enduring predisposition to generate seizures. Treatment of epilepsy with standard anticonvulsants such as phenytoin, carbamazepine, valproic acid and phenobarbital is often complicated by side effects. Thus, there is an unmet need for a highly efficacious AED with a good safety profile and very few side effects. A host of newer AEDs or modified versions of the previously available drugs, are available which if not more are at least equally efficacious to the older AEDs with a better safety profile and fewer drug interactions.

Keywords: NEWER ANTI EPILEPTIC DRUGS

How to Cite?: Dr. Neera Chaudhry, Dr. Abhilekh Srivastava, Dr. Cankatika Choudhury, "Newer Anti Epileptic Drugs", Volume 9 Issue 3, March 2020, International Journal of Science and Research (IJSR), Pages: 281-285, https://www.ijsr.net/getabstract.php?paperid=SR20225203618, DOI: https://dx.doi.org/10.21275/SR20225203618

Download Citation: APA | MLA | BibTeX | EndNote | RefMan

Share This Research

Help this article reach readers, researchers and professionals.

Share activity is measured for research-engagement analytics. Only verified, unique public shares can support award tie-breaking.

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.

Download Article PDF


Rate This Article!

Top

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.